We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Autocode Blood Glucose Monitoring System Eliminates Need for Manual Coding

By LabMedica International staff writers
Posted on 03 Feb 2010
A blood glucose monitoring system's autocoding eliminates the need for any other form of manual coding, which can reduce user error, thereby ensuring more consistent, accurate results. These meters are uniquely designed for long-term care and multiresident use settings.

Arkray, Inc. (Edina, MN,USA) has officially launched the new Assure Platinum blood glucose monitoring system. The Assure Platinum is now available for order and ready to ship in the U.S. market. The Assure Platinum blood glucose monitoring system received 510(k) clearance from the U.S. Food and Drug Demonstration (FDA) in December 2009. With high demand for an autocode system appropriate for long-term care and multipatient settings means, Arkray anticipates the Assure Platinum will quickly gain market share.

Assure Platinum is the first autocode Assure brand blood-glucose meter. The meter helps facilities meet state regulatory standards and provide better resident care. Assure Blood glucose meters are backed by the Assure Brilliance program, a comprehensive service program from the leaders of diabetes management in long-term care. Assure Brilliance provides customer service, on-site training, quality assurance/quality control (QA/QC) guidance, diabetes F-Tag advice for long-term care, a quarterly newsletter, online continuing education programs, and more to help facilities manage complex diabetes care in their facilities.

Related Links:
Arkray



Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
HPV Molecular Test
BD Onclarity HPV Assay
Immunofluorescence Analyzer
IFA System

Channels

Clinical Chemistry

view channel
Image: Researchers use a novel immobilized liposome-bound gel beads method to measure CEC levels and their association with cardiovascular risks (Photo courtesy of Institute of Science Tokyo)

Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features

Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
ADLM